Bokf Na Acquires New Stake in Innospec Inc. (NASDAQ:IOSP)

Bokf Na bought a new stake in shares of Innospec Inc. (NASDAQ:IOSPFree Report) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 2,664 shares of the specialty chemicals company’s stock, valued at approximately $329,000.

Several other institutional investors also recently bought and sold shares of IOSP. TFO Wealth Partners LLC boosted its stake in shares of Innospec by 29,800.0% in the fourth quarter. TFO Wealth Partners LLC now owns 299 shares of the specialty chemicals company’s stock valued at $37,000 after purchasing an additional 298 shares during the period. DekaBank Deutsche Girozentrale acquired a new stake in Innospec during the 1st quarter worth approximately $66,000. CWM LLC boosted its position in Innospec by 239.6% in the 2nd quarter. CWM LLC now owns 635 shares of the specialty chemicals company’s stock valued at $78,000 after buying an additional 448 shares during the period. Motco acquired a new position in shares of Innospec in the first quarter worth $132,000. Finally, EntryPoint Capital LLC purchased a new stake in shares of Innospec during the first quarter worth $147,000. 96.64% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Innospec

In other news, CFO Ian Cleminson sold 3,398 shares of the stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $114.74, for a total value of $389,886.52. Following the transaction, the chief financial officer now owns 12,996 shares in the company, valued at approximately $1,491,161.04. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.52% of the stock is owned by insiders.

Innospec Stock Performance

IOSP stock opened at $109.91 on Tuesday. The company’s 50 day moving average price is $116.58 and its 200 day moving average price is $122.10. The firm has a market capitalization of $2.74 billion, a price-to-earnings ratio of 18.66 and a beta of 1.08. Innospec Inc. has a fifty-two week low of $95.69 and a fifty-two week high of $133.71.

Innospec (NASDAQ:IOSPGet Free Report) last announced its quarterly earnings data on Tuesday, August 6th. The specialty chemicals company reported $1.39 EPS for the quarter, beating analysts’ consensus estimates of $1.37 by $0.02. The company had revenue of $435.00 million for the quarter, compared to the consensus estimate of $468.73 million. Innospec had a net margin of 7.90% and a return on equity of 14.15%. The company’s quarterly revenue was down 9.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.28 EPS. Equities analysts forecast that Innospec Inc. will post 5.95 EPS for the current fiscal year.

Analyst Ratings Changes

Separately, StockNews.com cut Innospec from a “strong-buy” rating to a “buy” rating in a research note on Thursday, August 8th.

Read Our Latest Analysis on IOSP

About Innospec

(Free Report)

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.

See Also

Institutional Ownership by Quarter for Innospec (NASDAQ:IOSP)

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.